Pictet Asset Management (UK)’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | $5.33M | Sell |
247,538
-72,395
| -23% | -$1.56M | 0.01% | 828 |
|
2021
Q1 | $4.81M | Sell |
319,933
-43,300
| -12% | -$650K | 0.01% | 836 |
|
2020
Q4 | $4.77M | Sell |
363,233
-26,200
| -7% | -$344K | 0.01% | 815 |
|
2020
Q3 | $3.76M | Sell |
389,433
-90,751
| -19% | -$877K | 0.01% | 787 |
|
2020
Q2 | $5.49M | Sell |
480,184
-95,068
| -17% | -$1.09M | 0.01% | 658 |
|
2020
Q1 | $5.96M | Buy |
575,252
+127,000
| +28% | +$1.32M | 0.01% | 593 |
|
2019
Q4 | $7.36M | Sell |
448,252
-71,648
| -14% | -$1.18M | 0.01% | 648 |
|
2019
Q3 | $6.9M | Buy |
519,900
+43,900
| +9% | +$583K | 0.01% | 608 |
|
2019
Q2 | $6.71M | Buy |
476,000
+104,200
| +28% | +$1.47M | 0.01% | 610 |
|
2019
Q1 | $6.84M | Buy |
371,800
+121,900
| +49% | +$2.24M | 0.02% | 607 |
|
2018
Q4 | $6.53K | Buy |
249,900
+68,100
| +37% | +$1.78K | 0.02% | 588 |
|
2018
Q3 | $4.17M | Sell |
181,800
-24,900
| -12% | -$571K | 0.01% | 761 |
|
2018
Q2 | $3.94M | Buy |
+206,700
| New | +$3.94M | 0.01% | 711 |
|